184
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series

, ORCID Icon, , , , & show all
Pages 169-177 | Published online: 09 Feb 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alicia Prieto-García, María Isabel Peligros, Isabel Pérez Tamayo, José Manuel Zubeldia, Luis Álvarez-Sala & Cristina Lavilla. (2023) Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing. Journal of Asthma 0:0, pages 1-3.
Read now

Articles from other publishers (4)

Hiroki Tashiro, Koichiro Takahashi, Masaru Uchida, Yuki Kurihara, Hironori Sadamatsu, Ayako Takamori, Shinya Kimura & Naoko Sueoka-Aragane. (2023) Effect of Azithromycin on Exacerbations in Asthma Patients with Obesity: Protocol for a Multi-Center, Prospective, Single-Arm Intervention Study. International Journal of Environmental Research and Public Health 20:3, pages 1861.
Crossref
Koichiro Asano, Yuzo Suzuki, Jun Tanaka, Konomi Kobayashi & Yosuke Kamide. (2023) Treatments of refractory eosinophilic lung diseases with biologics. Allergology International 72:1, pages 31-40.
Crossref
Daniel Griscti Soler, Alessandra Bennici, Silvia Brunetto, Sebastiano Gangemi & Luisa Ricciardi. (2022) Benralizumab in the management of rare primary eosinophilic lung diseases. Allergy and Asthma Proceedings 43:6, pages 494-500.
Crossref
. (2022) Prednisolone. Reactions Weekly 1916:1, pages 362-362.
Crossref